Amgen’s experimental bone drug reduced the risk of spinal fractures in women with osteoporosis by 68 percent in a pivotal clinical trial.
Amgen’s experimental bone drug reduced the risk of spinal fractures in women with osteoporosis by 68 percent in a pivotal clinical trial.
Sanofi-Aventis, the French pharmaceutical company, said that it had appointed an outsider with American experience to be chief executive, amid reports of friction among top management.
Sanofi-Aventis, the French pharmaceutical company, said that it had appointed an outsider with American experience to be chief executive, amid reports of friction among top management.